These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15456931)

  • 1. Brain injury-dependent expression of activity-dependent neuroprotective protein.
    Zaltzman R; Alexandrovich A; Beni SM; Trembovler V; Shohami E; Gozes I
    J Mol Neurosci; 2004; 24(2):181-7. PubMed ID: 15456931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury.
    Zaltzman R; Alexandrovich A; Trembovler V; Shohami E; Gozes I
    Peptides; 2005 Aug; 26(8):1520-7. PubMed ID: 16042992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
    Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
    Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.
    Dresner E; Agam G; Gozes I
    Eur Neuropsychopharmacol; 2011 May; 21(5):355-61. PubMed ID: 20598862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
    Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
    Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-dependent neuroprotective protein: from gene to drug candidate.
    Gozes I
    Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel VIP responsive gene. Activity dependent neuroprotective protein.
    Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
    Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis.
    Romano J; Beni-Adani L; Nissenbaum OL; Brenneman DE; Shohami E; Gozes I
    J Mol Neurosci; 2002; 18(1-2):37-45. PubMed ID: 11931348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent neuroprotective protein (ADNP) in the mouse brains.
    Nakamachi T; Ohtaki H; Yofu S; Dohi K; Watanabe J; Hayashi D; Matsuno R; Nonaka N; Itabashi K; Shioda S
    Regul Pept; 2008 Jan; 145(1-3):88-95. PubMed ID: 17942168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
    Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
    Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.
    Giladi E; Hill JM; Dresner E; Stack CM; Gozes I
    J Mol Neurosci; 2007; 33(3):278-83. PubMed ID: 17952637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury.
    Yatsiv I; Morganti-Kossmann MC; Perez D; Dinarello CA; Novick D; Rubinstein M; Otto VI; Rancan M; Kossmann T; Redaelli CA; Trentz O; Shohami E; Stahel PF
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):971-8. PubMed ID: 12172382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus.
    Furman S; Hill JM; Vulih I; Zaltzman R; Hauser JM; Brenneman DE; Gozes I
    Neurosci Lett; 2005 Jan; 373(1):73-8. PubMed ID: 15555780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.
    Poggi SH; Goodwin K; Hill JM; Brenneman DE; Tendi E; Schinelli S; Abebe D; Spong CY
    Am J Obstet Gynecol; 2003 Sep; 189(3):790-3. PubMed ID: 14526315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.
    Beni-Adani L; Gozes I; Cohen Y; Assaf Y; Steingart RA; Brenneman DE; Eizenberg O; Trembolver V; Shohami E
    J Pharmacol Exp Ther; 2001 Jan; 296(1):57-63. PubMed ID: 11123362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
    Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
    Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease.
    Gozes I
    J Neurosci Res; 2017 Jan; 95(1-2):652-660. PubMed ID: 27870441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.
    Braitch M; Kawabe K; Nyirenda M; Gilles LJ; Robins RA; Gran B; Murphy S; Showe L; Constantinescu CS
    Neuroimmunomodulation; 2010; 17(2):120-5. PubMed ID: 19923857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of activity-dependent neuroprotective protein in the brain of adult rats.
    Gennet N; Herden C; Bubb VJ; Quinn JP; Kipar A
    Histol Histopathol; 2008 Mar; 23(3):309-17. PubMed ID: 18072088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
    Gozes I
    Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.